VENETOCLAX‐OBINUTUZUMAB MODULATES CLONAL GROWTH: RESULTS OF A POPULATION‐BASED MINIMAL RESIDUAL DISEASE MODEL FROM THE RANDOMIZED CLL14 STUDY

Authors :: T Ching
Sebastian Böttcher
Yanwen Jiang
Eugen Tausch
C M Wendtner
Su Young Kim
Kirsten Fischer
A. M. Fink
M. Z Liao
Matthias Ritgen
T Lu
S. Stilgenbauer
Karl-Anton Kreuzer
Maneesh Tandon
D Miles
C. Zhang
Michael Hallek
Barbara Eichhorst
Anesh Panchal
Othman Al-Sawaf
Sandra Robrecht
Source :: Hematological Oncology. 39
Publication Year :: 2021
Publisher :: Wiley, 2021.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Venetoclax
Hematology
General Medicine
Population based
Biology
Minimal residual disease
chemistry.chemical_compound
chemistry
Obinutuzumab
Internal medicine
medicine
Clonal growth

Full Text Access

Tools